atorvastatin has been researched along with Acute Kidney Injury in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (12.68) | 29.6817 |
2010's | 51 (71.83) | 24.3611 |
2020's | 11 (15.49) | 2.80 |
Authors | Studies |
---|---|
Li, N; Xu, M; Yin, M; Zhao, G | 1 |
Gao, M; Jin, S; Tian, C; Yan, SX; Yang, TH | 1 |
Fomin, VV; Mironova, OI; Vasin, AA | 1 |
Li, CJ; Li, YJ; Su, BH; Yue, RZ; Zeng, R | 1 |
Avram, C; Baba, DF; Danilesco, A; Huma, L; Moldovan, DA; Rauta, RC; Sin, IA; Suciu, H | 1 |
Chatsudthipong, V; Cherngwelling, R; Jaikumkao, K; Lungkaphin, A; Pengrattanachot, N; Pongchaidecha, A; Swe, MT; Thongnak, L | 1 |
Chatsudthipong, V; Kongkaew, A; Lungkaphin, A; Thongnak, L | 1 |
Bellandi, F; Leoncini, M; Maioli, M; Toso, A; Tropeano, F; Villani, S | 1 |
Chen, H; Chen, J; Dai, Y; Duan, C; He, P; Huang, J; Huang, Z; Liu, Y; Shao, S; Tan, N; Xue, L; Yu, D; Zeng, L | 1 |
Alshogran, OY; Alzoubi, KH; El-Elimat, T; Nusair, SD; Obeidat, A; Sweidan, M | 1 |
Jiaqiong, L; Ming, L; Xiaoyong, L; Xinxue, L; Xuexian, T; Yan, L; Yinglan, L; Yue, G; Zena, H | 1 |
Aleta, M; Batra, J; Buttar, RS; Kreimerman, J; Melamed, ML | 1 |
Bei, WJ; Chen, JY; Chen, PY; Chen, SQ; Duan, C; Li, HL; Liu, Y; Tan, N; Wu, DX; Xie, NJ | 1 |
Huang, S; Su, B; Tao, Y; Yue, R; Zeng, J; Zeng, R; Zuo, C | 1 |
Billings, FT; Blume, JD; Linton, MF; Smith, DK; Smith, LE | 1 |
Fu, N; Liang, M; Yang, S | 1 |
Liu, LY; Liu, Y; Ma, FZ; Sun, YY; Wu, MY | 1 |
Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T | 1 |
Dalugama, C; Kularatne, SAM; Pathirage, M | 1 |
Chen, J; Dai, J; Mao, W; Qiu, Y; Wang, Z; Xu, H; Xu, X; Zhou, X | 1 |
Abdelfattah, S; Ahmad, Z; Hassan, SS; Motawie, A; Rizk, A; Thomann, C | 1 |
Mohamed, MFH; Saeed, AAM; Salameh, OK | 1 |
Chen, SM; Cheng, KJ; Imai, K; Lee, CM; Lee, JA; Lee, MC; Li, YC | 1 |
Liu, LY; Ma, FZ; Sun, T; Sun, YY; Wu, MY | 1 |
Chang, FC; Chen, JB; Chen, JH; Chen, JW; Chen, YL; Chen, YM; Huang, PH; Huang, TM; Ko, WJ; Kuo, YS; Liang, CJ; Lo, SC; Sun, CY; Wang, KC; Wu, KD; Wu, VC; Young, GH | 1 |
Dormuth, CR; Ernst, P; Garg, AX; Hemmelgarn, BR; James, MT; Lafrance, JP; Levy, A; Paterson, JM; Raymond, CB; Teare, GF | 1 |
Lei, W; Li, H; Tian, J; Wu, K | 1 |
Cai, W; Cao, Y; Chen, X; Li, S; Ma, W; Su, J; Wang, F; Zou, W | 1 |
Campese, VM | 1 |
Cong, H; Fu, N; Jin, D; Li, H; Li, X; Ma, H; Wang, Y | 1 |
Bellandi, F; Colonna, G; Di Sciascio, G; Grieco, D; Leoncini, M; Maioli, M; Patti, G; Toso, A | 1 |
Cannon, CP; de Lemos, J; Guo, J; Lewis, EF; Mega, JL; O'Donoghue, ML; Rouleau, JL; Sabatine, MS; Sarma, A | 1 |
Bangalore, S; DeMicco, DA; Fayyad, R; Hovingh, GK; Laskey, R; Vogt, L; Waters, DD | 1 |
Panchangam, V | 1 |
Cai, J; Ding, X; Fang, Y; Liu, S; Liu, T; Yu, X; Zhang, B; Zhang, H | 1 |
Horoshko, OM; Zamors'kyĭ, II; Zeleniuk, VH | 1 |
Choi, D; Hong, N; Kang, SM; Lee, SH; Oh, J; Park, S; Youn, JC | 1 |
Akiyama, E; Kimura, K; Kosuge, M | 1 |
Fang, M; Han, H; Li, D; Wang, H; Wu, H | 1 |
Hamza, M; Shehata, M | 1 |
Lewicki, M; Ng, I; Schneider, AG | 1 |
Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP | 1 |
Caran, T; Cibicek, N; Cibickova, L; Dobias, M; Ondra, P; Vorisek, V | 1 |
Dormanesh, B; Ghaznavi, H; Hosseini Tabatabaei, SM; Hosseinzadeh, A; Kamrava, SK; Mehrzadi, S; Motevalian, M | 1 |
Bellomo, R | 1 |
Billings, FT; Brown, NJ; Byrne, JG; Hendricks, PA; Petracek, MR; Schildcrout, JS; Shi, Y | 1 |
Arjinajarn, P; Chatsudthipong, V; Chattipakorn, N; Jaikumkao, K; Lungkaphin, A; Pongchaidecha, A; Promsan, S | 1 |
Kwak, YL; Park, JH; Shim, JK; Soh, S; Song, JW | 1 |
Chen, J; He, X; Li, L; Tan, H; Zhou, Y | 1 |
Xu, G; Yang, P | 1 |
Billings, FT; Brown, NJ | 1 |
Chen, J; He, X; Li, L; Ran, P; Sun, S; Tan, H; Wu, Y; Yang, J; Zhou, Y | 1 |
Alexandropoulos, D; Arkadopoulos, N; Bazigos, GV; Doulamis, IP; Kondi-Pafiti, A; Konstantopoulos, P; Kotsis, T; Perrea, DN; Smyrniotis, V; Tragotsalou, N; Tzani, A | 1 |
Chen, GL; Su, JZ | 1 |
Amato, M; Bellandi, F; Gallopin, M; Leoncini, M; Maioli, M; Manzone, C; Micheletti, C; Tedeschi, D; Toso, A | 1 |
Alemdar, R; Aydin, M; Basar, C; Caglar, O; Erden, I; Ordu, S; Ozhan, H; Yalcin, S | 1 |
Bagshaw, SM; Bellomo, R; Cruz, DN; Gibney, N; Haase, M; Honore, PM; Joannes-Boyau, O; McAlister, FA; Palevsky, PM; Prowle, J; Ronco, C | 1 |
Abu-Fadel, MS; Pappy, R | 1 |
Bagshaw, SM; Bellomo, R; Calzavacca, P; Devarajan, P; Echeverri, JE; Haase, M; Haase-Fielitz, A; Licari, E; Ligabo, EV; Prowle, JR | 1 |
Cai, WQ; Chai, DJ; Chen, GL; Chen, XP; Huang, QY; Su, JZ; Wang, FB; Xue, Y; Zhang, DS | 1 |
Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S | 1 |
Enache, I; Garrouste, C; Heng, AE; Kaysi, S; Philipponnet, C; Tiple, A | 1 |
Bianco, A; Briguori, C; Colombo, A; Condorelli, G; De Micco, F; Donnarumma, E; Fiore, D; Focaccio, A; Golia, B; Quintavalle, C; Ricciardelli, B; Troncone, G; Visconti, G; Zabatta, MA | 1 |
Lewin, JJ; Nappi, JM; Taylor, MH | 1 |
Andreucci, M; Cianciaruso, B; Fuiano, G; Paternò, R; Pisani, A; Sabbatini, M; Serio, V; Serù, R; Uccello, F | 1 |
Satish, B; Unnikrishnan, D | 1 |
Jellinek, SP; Mahboobi, SK; Rose, M; Shohat, EZ | 1 |
Ho, L; Levidiotis, V; Lim, AK | 1 |
Ho, W; Huo, Y; Liu, ZP; Meng, L | 1 |
Johnson, A; Zager, RA | 1 |
Castro, JG; Gutierrez, L | 1 |
9 review(s) available for atorvastatin and Acute Kidney Injury
Article | Year |
---|---|
Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis.
Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Coronary Angiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic | 2018 |
Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis.
Topics: Acute Kidney Injury; Aged; Atorvastatin; Cardiac Catheterization; Comparative Effectiveness Research; Contrast Media; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Risk Factors; Rosuvastatin Calcium; Treatment Outcome | 2019 |
Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Coronary Angiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Percutaneous Coronary Intervention | 2019 |
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
Topics: Acute Kidney Injury; Adult; Aged; Atorvastatin; British Columbia; Cohort Studies; Confidence Intervals; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorobenzenes; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Safety; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Simvastatin; Sulfonamides; United Kingdom; United States | 2013 |
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.
Topics: Acute Kidney Injury; Atorvastatin; Disease Progression; Dyslipidemias; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney; Kidney Diseases; Male; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Sulfonamides | 2014 |
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
Topics: Acute Kidney Injury; Aged; Atorvastatin; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Evaluation Studies as Topic; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Survival Analysis | 2014 |
Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Atorvastatin; Contrast Media; Coronary Angiography; Creatinine; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Pyrroles; Randomized Controlled Trials as Topic | 2015 |
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
Topics: Acute Kidney Injury; Adult; Atorvastatin; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Artery Bypass; Creatinine; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2015 |
Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
Topics: Acute Kidney Injury; Atorvastatin; Cardiovascular Diseases; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Risk; Rosuvastatin Calcium; Simvastatin | 2015 |
14 trial(s) available for atorvastatin and Acute Kidney Injury
Article | Year |
---|---|
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Coronary Angiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Prospective Studies; Rosuvastatin Calcium | 2020 |
High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Atorvastatin; Cardiac Surgical Procedures; Cholesterol, HDL; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Postoperative Period; Preoperative Period; Risk Factors; Treatment Outcome | 2017 |
High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Atorvastatin; Biomarkers; Contrast Media; Creatinine; Cystatin C; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Treatment Outcome | 2018 |
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Atorvastatin; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pravastatin; Pyrroles | 2014 |
Effect of high-dose statin loading on biomarkers related to inflammation and renal injury in patients hospitalized with acute heart failure. Randomized, controlled, open-label, prospective pilot study.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Aged, 80 and over; Atorvastatin; Biomarkers; Female; Heart Failure; Heptanoic Acids; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles | 2014 |
Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Topics: Acute Kidney Injury; Atorvastatin; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Double-Blind Method; Egypt; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Protective Factors; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome | 2015 |
High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aspartate Aminotransferases; Atorvastatin; Cardiac Surgical Procedures; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Postoperative Complications; Renal Insufficiency, Chronic | 2016 |
Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Atorvastatin; Biomarkers; Cardiopulmonary Bypass; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Perioperative Period; Postoperative Complications; Prospective Studies | 2016 |
[Atorvastatin attenuated contrast induced renal function damage].
Topics: Acute Kidney Injury; Aged; Atorvastatin; Contrast Media; Coronary Angiography; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles | 2009 |
Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Renal Insufficiency, Chronic; Risk Factors | 2010 |
Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Atorvastatin; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles | 2010 |
Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Atorvastatin; Cardiac Surgical Procedures; Creatinine; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipocalin-2; Lipocalins; Male; Middle Aged; Multivariate Analysis; Pilot Projects; Postoperative Complications; Proto-Oncogene Proteins; Pyrroles | 2012 |
[Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; C-Reactive Protein; Contrast Media; Female; Heptanoic Acids; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles | 2011 |
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Animals; Atorvastatin; Cells, Cultured; Contrast Media; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; Middle Aged; Pyrroles; Tumor Suppressor Protein p53 | 2012 |
48 other study(ies) available for atorvastatin and Acute Kidney Injury
Article | Year |
---|---|
Atorvastatin (ATV)-Loaded Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhance the Therapeutic Efficacy of Acute Kidney Injury.
Topics: Acute Kidney Injury; Atorvastatin; Humans; Hydrogen Peroxide; Lipid Bilayers; Nanoparticles; Silicon Dioxide | 2021 |
The preventive effects of different doses of atorvastatin on contrast-induced acute kidney injury after CT perfusion.
Topics: Acute Kidney Injury; Atorvastatin; Biomarkers; C-Reactive Protein; Contrast Media; Creatinine; Glomerular Filtration Rate; Humans; Interleukin-6; Perfusion; Tomography, X-Ray Computed | 2022 |
[The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media].
Topics: Acute Kidney Injury; Atorvastatin; Cardiovascular Diseases; Contrast Media; Creatinine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed | 2022 |
Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Caspases; Contrast Media; Epithelial Cells; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats; Signal Transduction; Toll-Like Receptor 4 | 2023 |
The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts-A Retrospective Single-Center Cohort Study.
Topics: Acute Kidney Injury; Atorvastatin; Cholesterol, LDL; Cohort Studies; Diabetes Mellitus, Type 2; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Retrospective Studies | 2023 |
Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation.
Topics: Acute Kidney Injury; Animals; Antioxidants; Atorvastatin; Diet, High-Fat; Humans; Inflammation; Insulin; Insulin Resistance; Kidney; Lipid Metabolism; Obesity; Organic Anion Transporters, Sodium-Independent; Oxidative Stress; Rats; Rats, Wistar | 2020 |
Effects of dapagliflozin and statins attenuate renal injury and liver steatosis in high-fat/high-fructose diet-induced insulin resistant rats.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Benzhydryl Compounds; Blotting, Western; Dietary Carbohydrates; Dietary Fats; Drug Therapy, Combination; Fatty Liver; Fructose; Glucosides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; Rats; Rats, Wistar | 2020 |
Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Atorvastatin; Biomarkers; Contrast Media; Creatinine; Female; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Factors; Rosuvastatin Calcium; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome; Up-Regulation | 2020 |
Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Atorvastatin; Contrast Media; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Drug Therapy, Combination; Male; Rats; Rats, Sprague-Dawley; Ubiquinone | 2021 |
Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide.
Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; Contrast Media; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Hydrogen Sulfide; Inflammation; Kidney; Male; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Sulfides; Up-Regulation | 2020 |
Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.
Topics: Acute Kidney Injury; Aged, 80 and over; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis; Sitagliptin Phosphate; Vitamin D | 2017 |
Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography.
Topics: Acute Kidney Injury; Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Contrast Media; Coronary Angiography; Creatinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Protective Agents; Risk; Time Factors; Treatment Failure | 2017 |
Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Blood Urea Nitrogen; Contrast Media; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Function Tests; Kidney Tubules; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2017 |
Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Atorvastatin; Buthionine Sulfoximine; Ciprofloxacin; Creatine Kinase; Disease Models, Animal; Drug Interactions; Female; Glutathione Synthase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Rhabdomyolysis | 2018 |
Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.
Topics: Acute Kidney Injury; Adult; Atorvastatin; Creatinine; Cytochrome P-450 CYP2C8 Inhibitors; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Polypharmacy; Rhabdomyolysis; Risk Factors | 2018 |
Preconditioning with atorvastatin against renal ischemia-reperfusion injury in nondiabetic versus diabetic rats.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Diabetes Mellitus, Experimental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning; Kidney Cortex; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death.
Topics: Acute Kidney Injury; Aged; Atorvastatin; Chemical and Drug Induced Liver Injury; Fatal Outcome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis | 2019 |
A novel preventive mechanism of gentamicin-induced nephrotoxicity by atorvastatin.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Gentamicins; Kidney; Male; Oxidative Stress; Protective Agents; Rats; Rats, Wistar | 2019 |
In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Animals; Apoptosis; Atorvastatin; Blotting, Western; Centrifugation, Density Gradient; Endothelial Cells; Female; Flow Cytometry; Gene Expression Regulation; Heptanoic Acids; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Indican; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nitric Oxide Synthase Type III; Pyrroles; Reactive Oxygen Species; Stem Cells; Taiwan; Vascular Cell Adhesion Molecule-1 | 2013 |
Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats.
Topics: Acute Kidney Injury; Animals; Anticholesteremic Agents; Atorvastatin; Disease Models, Animal; Glomerular Filtration Rate; Heptanoic Acids; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome | 2014 |
Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway.
Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Contrast Media; Diabetes Mellitus, Experimental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iohexol; Kidney Tubules; Male; Protein Phosphatase 1; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Rats; Rats, Wistar; rho-Associated Kinases | 2014 |
Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.
Topics: Acute Kidney Injury; Aged; Antioxidants; Atorvastatin; Biomarkers; Contrast Media; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Function Tests; Male; Middle Aged; Perioperative Period; Probucol; Prospective Studies; Pyrroles; Risk Factors; Uric Acid | 2014 |
Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Atorvastatin; Contrast Media; Disease-Free Survival; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Percutaneous Coronary Intervention; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2014 |
Statin-associated acute interstitial nephritis and rhabdomyolysis.
Topics: Acute Kidney Injury; Atorvastatin; Glucocorticoids; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nephritis, Interstitial; Prednisolone; Pyrroles; Renal Dialysis; Rhabdomyolysis; Time Factors; Treatment Outcome | 2014 |
Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Graft Survival; Heptanoic Acids; HMGB1 Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunity, Innate; Inflammation; Kidney; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Oxidative Stress; Pyrroles; Rats; Reperfusion Injury; Toll-Like Receptor 4 | 2014 |
[Renoprotective efficacy of different doses of statins in experimental acute renal failure].
Topics: Acute Kidney Injury; Administration, Topical; Animals; Atorvastatin; Creatine Kinase; Diuresis; Glomerular Filtration Rate; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lovastatin; Pyrroles; Rats; Rhabdomyolysis; Simvastatin; Stomach; Urodynamics | 2014 |
Is high-dose statin loading effective for acute decompensated heart failure? Insight of inflammation and acute kidney injury.
Topics: Acute Kidney Injury; Atorvastatin; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pyrroles | 2014 |
Multi-drug intoxication fatality involving atorvastatin: A case report.
Topics: Acute Kidney Injury; Aged; Alcoholics; Anthraquinones; Anti-Inflammatory Agents; Antihypertensive Agents; Atorvastatin; Drug Overdose; Female; Forensic Toxicology; Gastrointestinal Contents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Piperazines; Rhabdomyolysis; Suicide; Vasodilator Agents; Verapamil | 2015 |
Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Creatinine; Drug Synergism; Gentamicins; Glutathione; Kidney; Kidney Function Tests; Male; Malondialdehyde; Melatonin; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Urea | 2016 |
Perioperative Statins in Cardiac Surgery and Acute Kidney Injury.
Topics: Acute Kidney Injury; Atorvastatin; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male | 2016 |
Atorvastatin improves renal organic anion transporter 3 and renal function in gentamicin-induced nephrotoxicity in rats.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Gentamicins; Kidney; Male; Organic Anion Transporters, Sodium-Independent; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2016 |
Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Atorvastatin; Caspase 3; Cell Line; Contrast Media; Creatinine; Cytokines; HSP27 Heat-Shock Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iopamidol; JNK Mitogen-Activated Protein Kinases; Kidney; Male; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley | 2016 |
Statins to Reduce Acute Kidney Injury After Cardiac Surgery.
Topics: Acute Kidney Injury; Atorvastatin; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male | 2016 |
Statins to Reduce Acute Kidney Injury After Cardiac Surgery--Reply.
Topics: Acute Kidney Injury; Atorvastatin; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male | 2016 |
Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro.
Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; Cell Line; Contrast Media; HSP27 Heat-Shock Proteins; Humans; Iopamidol; Kidney; Male; Protective Agents; Rats; Up-Regulation | 2017 |
Protective effects of N-acetylcystein and atorvastatin against renal and hepatic injury in a rat model of intestinal ischemia-reperfusion.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Atorvastatin; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestines; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2017 |
Recent trials in critical care nephrology.
Topics: Acute Kidney Injury; Atorvastatin; Critical Care; Critical Illness; Decision Support Systems, Clinical; Evidence-Based Medicine; Female; Hemofiltration; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Male; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Pyrroles; Random Allocation; Randomized Controlled Trials as Topic; Renal Circulation; Renal Dialysis; Renal Replacement Therapy; Sepsis; Severity of Illness Index; Survival Rate | 2010 |
Additional data supporting the use of statins to prevent contrast induced nephropathy.
Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment | 2011 |
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Genetic Predisposition to Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pantoprazole; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Pyrroles; Renal Dialysis; Rhabdomyolysis; Risk Factors; Treatment Outcome | 2012 |
Severe colchicine intoxication in a renal transplant recipient on cyclosporine.
Topics: Acute Kidney Injury; Atorvastatin; Colchicine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrroles; Quadriplegia; Rhabdomyolysis; Treatment Outcome | 2012 |
Rhabdomyolysis with concurrent atorvastatin and diltiazem.
Topics: Acute Disease; Acute Kidney Injury; Atorvastatin; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis | 2002 |
Atorvastatin improves the course of ischemic acute renal failure in aging rats.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Kidney; Male; Pyrroles; Rats; Rats, Sprague-Dawley | 2004 |
Exertion-induced rhabdomyolysis in a patient on statin therapy.
Topics: Acute Kidney Injury; Atorvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hyperlipidemias; Long-Term Care; Male; Middle Aged; Physical Exertion; Pyrroles; Rhabdomyolysis; Risk Assessment; Severity of Illness Index | 2005 |
Systemic infections can decrease the threshold of statin-induced muscle injury.
Topics: Acute Kidney Injury; Aged, 80 and over; Atorvastatin; Bacteremia; Enterococcus faecalis; Escherichia coli; Heart Valve Prosthesis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscular Diseases; Pyrroles | 2006 |
Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation.
Topics: Acute Kidney Injury; Anticholesteremic Agents; Atorvastatin; Disseminated Intravascular Coagulation; Drug Synergism; Female; Hemolytic-Uremic Syndrome; Heptanoic Acids; Humans; Middle Aged; Muscle Relaxants, Central; Pyrroles; Quinine; Rhabdomyolysis; Sleep-Wake Transition Disorders | 2006 |
Clinical characteristics and outcomes of Chinese patients with cholesterol crystal embolism after coronary intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Arteriosclerosis; Atorvastatin; China; Coronary Angiography; Embolism, Cholesterol; Female; Heptanoic Acids; Humans; Hypolipidemic Agents; Male; Prognosis; Prospective Studies; Pyrroles; Risk Assessment; Risk Factors; Simvastatin; Treatment Outcome | 2006 |
Renal cortical cholesterol accumulation is an integral component of the systemic stress response.
Topics: Acute Kidney Injury; Animals; Atorvastatin; Blotting, Western; Cell Line; Cholesterol; Cholesterol Esters; Escherichia coli Infections; Glycerol; Heptanoic Acids; Hot Temperature; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Cortex; Male; Mice; Mice, Inbred Strains; Pyrroles; Shock; Stress, Physiological | 2001 |
Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
Topics: Acute Kidney Injury; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delavirdine; Drug Interactions; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mixed Function Oxygenases; Pyrroles; Rhabdomyolysis | 2002 |